That is not negligible when you are simultaneously introducing a new GLP-1 agonist
While some compounded GLP-1s closely mimic the original formulations, others differ significantly, and even small changes in dose timing or delivery can affect how the drug performs
The main risk is hypoglycemia (dangerously low blood sugar), which can become a medical emergency
However, the landscape has changed significantly with Novo Nordisks new cash-pay pricing of $349 monthly, which provides brand-name Ozempic at a much more accessible price point than the $997 list price
The belief is that dual or triple-target therapies (GLP-1 + GIP + glucagon agonists) can push weight loss closer to 2530%, potentially rivaling surgical results
Understanding the timeline of these two drugs can provide insight into their development and the milestones achieved in diabetes treatment